Sponsor content
9 result(s) found, displaying 1 to 9
-
Australian Public Assessment Report (AusPAR)Slenyto (Melatonin) is approved to treat insomnia in children and adolescents with ASD, certain neurogenetic disorders (ages 2-18), or ADHD (ages 6-17) when sleep hygiene measures alone have not been effective.
-
Prescription medicine registrationActive ingredients: melatonin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VIGISOM melatonin 2 mg prolonged release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SLENYTO melatonin 1 mg prolonged release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SLENYTO melatonin 5 mg prolonged release tablet blister pack.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Melatonin
-
Prescription medicine registrationActive ingredients: melatonin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIRCADIN melatonin 2 mg prolonged release tablet blister pack.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Melatonin